[1]李 勇,王 丹,井丽红,等.扶阳保肾方对糖尿病肾病合并Ⅳ型心肾综合征患者血清指标的影响[J].陕西中医,2024,(3):365-368.[doi:DOI:10.3969/j.issn.1000-7369.2024.03.017]
　LI Yong,WANG Dan,JING Lihong,et al.Effect of Fuyang Baoshen recipe on serum indexes of diabetes nephropathy patients with type Ⅳcardiorenal syndrome[J].,2024,(3):365-368.[doi:DOI:10.3969/j.issn.1000-7369.2024.03.017]
点击复制

扶阳保肾方对糖尿病肾病合并Ⅳ型心肾综合征患者血清指标的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年3期
页码:
365-368
栏目:
临床研究
出版日期:
2024-03-05

文章信息/Info

Title:
Effect of Fuyang Baoshen recipe on serum indexes of diabetes nephropathy patients with type Ⅳcardiorenal syndrome
作者:
李 勇; 王 丹; 井丽红; 徐 丽; 邱溢博
(黑龙江中医药大学附属第二医院中医内科,黑龙江 哈尔滨 150001)
Author(s):
LI Yong; WANG Dan; JING Lihong; XU Li; QIU Yibo
(The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine,Harbin 150001,China)
关键词:
糖尿病肾病;  心肾综合征;  扶阳保肾方;  尿素氮;  肌酐;  中医证候积分
Keywords:
Diabetic nephropathy;  Cardiorenal syndrome;  Fuyang Baoshen recipe;  Blood urea nitrogen;  Creatinine;  Traditional Chinese medicine syndrome score
分类号:
R 587.1
DOI:
DOI:10.3969/j.issn.1000-7369.2024.03.017
文献标志码:
A
摘要:
目的:研究扶阳保肾方对糖尿病肾病合并Ⅳ型心肾综合征患者血清指标的影响。方法:选取120例糖尿病肾病合并Ⅳ型心肾综合征心肾阳虚证患者进行试验,按随机数字表法分为观察组与对照组,每组60例。两组均进行运动、戒烟、吸氧等常规治疗。对照组进行常规西药治疗,包括口服缬沙坦胶囊、胰岛素制剂; 观察组在对照组基础上使用扶阳保肾方进行治疗。观察两组治疗效果,记录两组治疗前后中医证候积分,测定两组治疗前后超敏C反应蛋白(Hs-CRP)、肌酐(CREA)、尿素氮(BUN)、血清β2微球蛋白(β2-MG)、脑钠肽(BNP)水平,观察两组不良反应发生率。结果:观察组治疗效果优于对照组。治疗后两组患者各项中医证候积分下降,且观察组心悸、胸闷气短、下肢浮肿、身寒肢冷评分低于对照组,差异有统计学意义(均P<0.05)。治疗后观察组BUN、CREA、β2-MG、Hs-CRP、BNP低于对照组,差异有统计学意义(均P<0.05)。两组不良反应比较,差异无统计学意义(P>0.05)。结论:扶阳保肾方治疗糖尿病肾病合并Ⅳ型心肾综合征效果较好,对肾功能改善明显,且能降低患者血清BUN、CREA水平及炎症反应,未增加患者不良反应。
Abstract:
Objective:To study effect of Fuyang Baoshen recipe on serum indexes of diabetes nephropathy patients with type ivcardiorenal syndrome.Methods:120 cases of diabetic nephropathy complicated with type ivcardiorenal syndrome with heart-kidney yang deficiency were selected for the experiment,and were randomly divided into observation group and control group,with 60 cases in each group.Both groups received routine treatment such as exercise,smoking cessation,and oxygen inhalation.The control group received routine western medicine treatment,including oral administration of valsartan capsules and the use of insulin preparations to lower blood sugar.The observation group were treated with Fuyang Baoshen formula on the basis of the control group.Observe treatment effects of two groups and record the TCM syndrome scores before and after treatment.Measure the levels of hypersensitive C-reactive protein(Hs-CRP),creatinine(CREA),urea nitrogen(BUN),and serum in two groups before and after treatment β2 microglobulin(β2-MG)and brain natriuretic peptide(BNP)levels.Observe the incidence of adverse reactions in both groups.Results:The therapeutic effect of the observation group were significantly better than that of the control group.After treatment,the scores of TCM syndromes in the two groups decreased significantly,and the scores of palpitation,chest tightness and shortness of breath,edema of lower limbs and cold body and limbs in the observation group were lower than those in the control group(P<0.05).After treatment,BUN,CREA,β2-MG,Hs-CRP,BNP in the observation group were lower than those in the control group(P<0.05).There was no significant difference in adverse reactions between the two groups(P>0.05).Conclusion:Fuyang Baoshen recipe has significant effect in treating diabetic nephropathy with type Ⅳ cardiorenal syndrome,obviously improving renal function,reducing levels of serum BUN and CREA,reducing the inflammatory reaction of patients,and not increasing the risk of adverse reactions.

参考文献/References:

[1] 杨亚兰,何凯颖,王俭勤.尿肾小管标志物与糖尿病肾病的临床研究进展[J].中国临床研究,2018,31(12):1705-1709.
[2] DIDI D,TANJA B,INGRID P.Diagnostic value and utility of commonly used biomarkers of cardiac and renal function in cardiorenal syndromes:A narrat Ⅳ review[J].Biochemia Medica,2023,33(3):30502.
[3] 盛红梅,汪瑛,陈少飞,等.益肾化浊汤治疗糖尿病肾病肾阴阳两虚证32例临床观察[J].安徽中医药大学学报,2023,42(4):29-33.
[4] 中华医学会糖尿病学分会微血管并发症学组.中国糖尿病肾脏疾病防治临床指南[J].中华糖尿病杂志,2019,11(1):15-28.
[5] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:23-28.
[6] 佟翠艳,何瑞,李春辉.高龄老年心肾综合征患者按心功能分级治疗50例报道[J].中华老年多器官疾病杂志,2013,12(10):783-785.
[7] 舒立极,柯亨记.加味参芪地黄汤联合替米沙坦片对早期糖尿病肾病患者中医证候积分、UARE、Cys-C的影响[J].四川中医,2019,37(12):117-119.
[8] 苏宏业,王乃尊.糖尿病肾病治疗研究[J].医学综述,2008,14(9):1376-1378.
[9] 杨其文,方晗语,李元,等.基于文献计量学分析黄芪在糖尿病肾病中的应用[J].医学综述,2022,28(3):596-604.
[10] 虞天璇,王琛.消白衍生方治疗糖尿病肾病Ⅲ-Ⅳ期患者尿蛋白的疗效观察[J].世界中西医结合杂志,2023,18(7):1396-1400.
[11] 曹春阳,田苗,李富震,等.中医药治疗糖尿病肾病实验研究进展[J].世界中医药,2023,18(14):2092-2097.
[12] 阮诺冰,方朝晖.中医药防治糖尿病肾脏病研究进展[J].中医药临床杂志,2023,35(7):1438-1442.
[13] 赵明刚,赵来法,丁世芹.固本逐瘀汤联合西药治疗早期糖尿病肾病临床研究[J].新中医,2023,55(13):90-93.
[14] 王淑娴,王敬斌,陈卫红.参芪益肾汤联合前列地尔对气阴两虚型糖尿病肾病患者肾功能及血管内皮功能的影响[J].海南医学,2023,34(12):1701-1705.
[15] 郑君,李群,曹吴冰,等.自拟益气养阴通络汤联合常规西药治疗糖尿病肾病的疗效观察及其对微血栓状态的影响[J].中国中医药科技,2023,30(4):689-691.
[16] 谌孙衡.通络保肾方治疗IgA肾病的临床研究[J].婚育与健康,2023,29(14):103-105.
[17] 王秀阁,闫冠池,金迪,等.基于AMPK/mTOR/ULK1通路探讨解毒通络保肾方改善糖尿病肾脏疾病的作用机制[J].北京中医药大学学报,2022,45(12):1213-1222.
[18] 云锐,张世光,孙良波.保肾通络方联合缬沙坦胶囊治疗糖尿病肾病临床研究[J].长春中医药大学学报,2020,36(4):699-702.
[19] 崔方强,王悦芬,孟元,等.保肾通络方含药血清对高糖培养足细胞Nephrin、Desmin蛋白表达及细胞凋亡的影响[J].陕西中医,2023,44(8):995-999.
[20] 王希亮,张艳丽,马超,等.真武汤合苓桂术甘汤联合厄贝沙坦治疗脾肾阳虚型糖尿病肾病患者的疗效评价[J].中外医疗,2023,42(18):30-34.
[21] 董怡,马静,余楠楠,等.大黄复方保留灌肠辅助治疗慢性肾脏病疗效及对患者生活质量的影响[J].陕西中医,2021,42(7):910-913.
[22] 徐智敏,刘华东.黄芪多糖对脓毒症小鼠肺组织炎症因子水平和细胞免疫的影响[J].世界中西医结合杂志,2022,17(11):2180-2184.
[23] 顾盼瑾,张立红,胡锡池,等.黄芪多糖联合替加环素对白细胞减少性鲍曼不动杆菌感染肺炎大鼠的疗效及机制研究[J].陕西医学杂志,2023,52(10):1319-1325.
[24] 蒋逸凡,金梦圆,周选围.茯苓多糖及其免疫调节功能研究进展[J].食用菌学报,2021,28(2):130-139.
[25] 熊宏泰,胡佳奇,杜炎远,等.五种植物多糖调节环磷酰胺诱导免疫抑制小鼠免疫功能的网状Meta分析[J].中国实验方剂学杂志,2023,29(6):210-221.
[26] 刘千红,侯亮,丘军,等.白芍总苷对IgA肾病患者炎性因子的影响[J].长春中医药大学学报,2018,34(3):512-514.

相似文献/References:

[1]张华贞.复方黄芪汤加减联合骨化三醇治疗糖尿病肾病疗效及对患者血糖、肾功的影响*[J].陕西中医,2019,(6):767.
[2]程红卫,成晓萍.阎晓萍从脾论治糖尿病肾病经验总结*[J].陕西中医,2019,(6):790.
[3]黄聪丽,王治新△.益气滋肾活血通络方治疗早中期糖尿病肾病临床研究[J].陕西中医,2019,(10):1390.
　HUANG Congli,WANG Zhixin..Clinical efficacy analysis of Yiqi Zishen Huoxue Tongluo decoctionon early and medium stage of diabetic nephropathy[J].,2019,(3):1390.
[4]玉山江·艾克木,哈丽达·木沙△,地丽尼嘎尔.西红康联合还原型谷胱甘肽治疗2型糖尿病肾病Ⅲ期气阴两虚夹瘀证疗效及对患者微炎症状态、抗氧化的影响*[J].陕西中医,2020,(3):338.
　Yushanjiang·Aikemu,Halida·Musha,Dilinigaer..Efficacy of adjuvant therapy of Xihongkang on type 2 diabetic nephropathy Ⅲ phase with syndrome of Qiyin Liangxu Jiayu type and its effect on micro inflammation and antioxidant role[J].,2020,(3):338.
[5]马民凯,马红建,陈新苗.通络散结汤对3期糖尿病肾病患者GFR、UAER、β2-MG、Cys-C及微炎症状态的影响*[J].陕西中医,2020,(10):1432.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.025]
[6]田娟娟,陈 强,周欣欣,等.益气养阴活血法治疗糖尿病肾病理论探究*[J].陕西中医,2020,(12):1781.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.026]
[7]代广玉,修丽梅.糖尿病肾病中医辨证分型研究进展[J].陕西中医,2021,(1):131.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.036]
[8]赵 亚,张勉之,樊威伟,等.国医大师张大宁治疗糖尿病肾病用药经验[J].陕西中医,2021,(6):773.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.025]
[9]张 蕊,王子承,蒋荣莉,等.防己黄芪汤加味治疗糖尿病肾病疗效及对患者糖脂代谢、氧化应激的影响[J].陕西中医,2021,(8):1049.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.015]
　ZHANG Rui,WANG Zicheng,JIANG Rongli,et al.Effect of Fangji Huangqi decoction on diabetic nephropathy and its influence on glucose and lipid metabolism and oxidative stress[J].,2021,(3):1049.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.015]
[10]方锦颖,王一冲,神原优滋(日本),等.基于网络药理学和分子对接探究肾康注射液治疗糖尿病肾病作用机制[J].陕西中医,2021,(12):1798.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.039]

备注/Memo

备注/Memo:
基金项目:黑龙江省中医药管理局中医药科研课题(ZHY2022-176)
更新日期/Last Update: 2024-03-08